SK Chemicals leads cell-culture-based vaccine production

SK Chemicals Co. is working hard to develop the next generation of influenza vaccines as well as pandemic vaccine candidates by utilizing its own cell-culture-based technology.

To this end, the company has recently succeeded in cultivating its own cell line “MDCK-SKY”, which is relatively advantageous for mass production with less cost and high yield.
SK officials said the company will carr...